HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sang-Cheol Bae Selected Research

Interferon Regulatory Factors

2/2013Associations between interferon regulatory factor 5 polymorphisms and rheumatoid arthritis: a meta-analysis.
11/2008Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population.
11/2008Putative role of functional interferon regulatory factor 5 (IRF5) polymorphism in rheumatoid arthritis in a Korean population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sang-Cheol Bae Research Topics

Disease

127Rheumatoid Arthritis
02/2022 - 08/2003
76Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 11/2002
14Autoimmune Diseases (Autoimmune Disease)
01/2020 - 01/2010
11Lupus Nephritis
09/2022 - 06/2007
10Infections
02/2022 - 04/2007
9Inflammation (Inflammations)
10/2019 - 03/2006
9Ankylosing Spondylitis
01/2018 - 08/2006
8Rheumatic Diseases (Rheumatism)
07/2021 - 02/2010
6Neoplasms (Cancer)
12/2021 - 05/2013
6Hypertension (High Blood Pressure)
10/2021 - 06/2013
6Arthritis (Polyarthritis)
05/2019 - 09/2003
6Osteoarthritis
01/2018 - 09/2003
6Tuberculosis (Tuberculoses)
01/2017 - 04/2007
5Proteinuria
10/2019 - 06/2013
5Pain (Aches)
04/2016 - 09/2003
4Necrosis
01/2021 - 01/2013
4Disease Susceptibility (Diathesis)
02/2018 - 11/2008
4Genetic Predisposition to Disease (Genetic Predisposition)
08/2016 - 06/2008
3Osteonecrosis (Kienbock's Disease)
01/2022 - 11/2013
3Vitamin D Deficiency
09/2016 - 12/2012
3Osteoporosis
09/2016 - 07/2014
3Nephritis
01/2016 - 04/2009
3Psoriatic Arthritis
05/2014 - 01/2013
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2013 - 05/2012
2Herpes Zoster
01/2022 - 01/2020
2Headache (Headaches)
12/2021 - 11/2013
2Thrombosis (Thrombus)
07/2021 - 11/2013
2Vasculitis (Vasculitides)
03/2019 - 03/2018
2Latent Tuberculosis
01/2018 - 06/2013

Drug/Important Bio-Agent (IBA)

23Methotrexate (Mexate)FDA LinkGeneric
02/2022 - 05/2005
19AutoantibodiesIBA
01/2021 - 01/2004
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2004
12Biological ProductsIBA
05/2022 - 11/2013
12Tumor Necrosis Factor InhibitorsIBA
01/2022 - 04/2007
10Etanercept (Enbrel)FDA Link
01/2017 - 04/2007
9GlucocorticoidsIBA
12/2021 - 01/2014
8HLA-DRB1 Chains (HLA DRB1)IBA
01/2021 - 11/2004
8AntibodiesIBA
01/2016 - 05/2007
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 06/2007
7Antirheumatic Agents (DMARD)IBA
05/2018 - 09/2010
7EpitopesIBA
06/2014 - 05/2007
6Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2012
6Anti-Citrullinated Protein AntibodiesIBA
06/2014 - 05/2007
5Adalimumab (Humira)FDA Link
02/2022 - 01/2013
5Immunosuppressive Agents (Immunosuppressants)IBA
12/2021 - 05/2015
5Vitamin DFDA LinkGeneric
10/2021 - 12/2012
5Biosimilar PharmaceuticalsIBA
04/2019 - 01/2017
5Infliximab (Remicade)FDA Link
05/2018 - 04/2007
5Protein Tyrosine PhosphatasesIBA
04/2018 - 04/2012
5Pharmaceutical PreparationsIBA
01/2018 - 12/2012
5Amino AcidsFDA Link
08/2016 - 01/2012
5DNA (Deoxyribonucleic Acid)IBA
01/2015 - 01/2004
5cyclic citrullinated peptideIBA
06/2014 - 05/2007
4golimumabFDA Link
01/2022 - 06/2010
4Interferon Type IIBA
01/2022 - 01/2010
4SteroidsIBA
01/2022 - 09/2010
4Antimalarials (Antimalarial Agents)IBA
12/2021 - 11/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 11/2013
4hydroxide ionIBA
10/2021 - 08/2014
4Biomarkers (Surrogate Marker)IBA
01/2020 - 11/2004
4C-Reactive ProteinIBA
05/2019 - 08/2006
4Rituximab (Mabthera)FDA Link
04/2019 - 11/2011
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 01/2014
4Interferon-gamma (Interferon, gamma)IBA
03/2015 - 11/2004
4Peptides (Polypeptides)IBA
03/2015 - 01/2012
4Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2013 - 02/2010
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2008 - 01/2005
3Antinuclear AntibodiesIBA
01/2022 - 08/2012
3Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022 - 05/2015
3belimumabIBA
01/2021 - 01/2016
3CreatinineIBA
10/2019 - 05/2013
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2019 - 01/2016
325-hydroxyvitamin DIBA
01/2018 - 08/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017 - 02/2009
3tofacitinibIBA
11/2016 - 09/2014
3ametantrone (HAQ)IBA
09/2016 - 01/2013
3IgG Receptors (Fc gamma RI)IBA
06/2016 - 10/2014
3HLA-B Antigens (HLA-B)IBA
11/2015 - 01/2012
3Tuberculin (PPD)IBA
03/2015 - 02/2013
3Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
12/2014 - 07/2006
3Interferon Regulatory FactorsIBA
02/2013 - 11/2008
3Interleukin-10 (Interleukin 10)IBA
01/2013 - 11/2004
3glutathione S-transferase M1IBA
12/2012 - 05/2004
3Interleukin-23 (Interleukin 23)IBA
12/2012 - 05/2009
3EnzymesIBA
01/2012 - 01/2005
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2010 - 01/2005
3AntioxidantsIBA
02/2009 - 11/2002
2GLPG0634IBA
02/2022 - 01/2021
2HLA-G Antigens (HLA G)IBA
02/2021 - 06/2015
2InterferonsIBA
01/2020 - 04/2012
2Tacrolimus (Prograf)FDA LinkGeneric
01/2019 - 02/2018
2Abatacept (Orencia)FDA Link
01/2019 - 11/2016
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
10/2018 - 01/2016
2CoffeeFDA Link
10/2018 - 11/2014
2tocilizumab (atlizumab)FDA Link
06/2018 - 11/2016
2Calcitriol Receptors (Calcitriol Receptor)IBA
06/2018 - 08/2011
2Macrophage Migration-Inhibitory FactorsIBA
02/2018 - 05/2012
2Interleukin-17 (Interleukin 17)IBA
01/2018 - 08/2017

Therapy/Procedure

29Therapeutics
01/2022 - 02/2004
3Tai Ji (Tai Chi Chuan)
03/2010 - 09/2003